---
schema_version: "secwatch.filing_event.v1"
accession: "0000818479-26-000263"
form_type: "8-K/A"
ticker: "XRAY"
cik: "0000818479"
company_name: "DENTSPLY SIRONA Inc."
filed_at: "2026-08-07T11:42:15+00:00"
generated_at: "2026-08-07T11:45:13.111168+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Dentsply Sirona Q2 2026: net sales $898M (-4.1% YoY), adj EPS $0.52 flat

## Summary
- Net sales $898M, down 4.1% YoY; GAAP diluted EPS $0.18 vs. ($0.22) loss in Q2 2025.
- Adjusted EPS $0.52 (flat YoY); adjusted gross margin 56.4%, adjusted EBITDA margin 21.3% (vs. 21.1%).
- Reiterates FY2026 outlook: net sales $3.5-3.6B, adjusted EPS $1.40-1.50; tariff refunds excluded.
- Repurchased 1.3M shares (~$12M); operating cash flow $99M vs. $48M, including ~$44M tariff refunds.
- Expanded Medline Sinclair partnership for Connected Technology Solutions portfolio across Canada.

## SEC filing metadata
- accession: 0000818479-26-000263
- form_type: 8-K/A
- ticker: XRAY
- cik: 0000818479
- company_name: DENTSPLY SIRONA Inc.
- filed_at: 2026-08-07T11:42:15+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 9.01, 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818479/000081847926000263/0000818479-26-000263-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818479/000081847926000263/xray-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000818479-26-000263
- JSON: https://secwatch.observer/filing/0000818479-26-000263.json
- Plain text: https://secwatch.observer/filing/0000818479-26-000263.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
